BB Biotech AG
Investing in a diversified portfolio of fast-growing biotech companies developing innovative drugs.
BION | SW
Overview
Corporate Details
- ISIN(s):
- CH0027659793 (+1 more)
- LEI:
- 391200MBZQNPFHIVKO34
- Country:
- Switzerland
- Address:
- Schwertstrasse 6, 8200 Schaffhausen
- Sector:
- Mining and quarrying
- Industry:
- Extraction of natural gas
Description
BB Biotech AG is a global investment company specializing in the biotechnology sector. With over 30 years of experience, it is one of the world's largest investors in this field. The company's strategy focuses on investing in publicly listed, fast-growing biotechnology firms that are developing and commercializing innovative drugs. Its portfolio targets companies whose products address significant unmet medical needs, thereby offering potential for above-average sales and profit growth. BB Biotech provides its shareholders with access to a diversified portfolio of high-growth potential companies within the biotech market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-24 07:00 |
Report Publication Announcement
BB Biotech AG publishes its interim report
|
English | 7.0 KB | ||
| 2025-10-24 02:00 |
Report Publication Announcement
EQS-Adhoc: BB Biotech AG publishes its interim report
|
English | 5.3 KB | ||
| 2025-10-24 02:00 |
Report Publication Announcement
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
|
German | 5.5 KB | ||
| 2025-10-24 02:00 |
Earnings Release
EQS-News: BB Biotech Q3 2025: Portfolio outperformance amid early signs of sect…
|
English | 21.4 KB | ||
| 2025-10-24 02:00 |
Earnings Release
EQS-News: BB Biotech Q3 2025: Portfolio übertrifft Benchmark – erste Anzeichen …
|
German | 23.1 KB | ||
| 2025-10-24 00:00 |
Interim Report
Q3 statement / Q3 financial report 2025
|
English | 5.7 MB | ||
| 2025-09-22 07:00 |
Environmental & Social Information
BB Biotech to be included in the SPI ESG Index
|
English | 6.5 KB | ||
| 2025-09-22 02:00 |
Environmental & Social Information
EQS-News: BB Biotech to be included in the SPI ESG Index
|
English | 5.2 KB | ||
| 2025-09-22 02:00 |
Environmental & Social Information
EQS-News: BB Biotech wird in den SPI ESG Index aufgenommen
|
German | 5.4 KB | ||
| 2025-09-01 16:40 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 24.0 KB | ||
| 2025-07-25 07:00 |
Report Publication Announcement
BB Biotech AG publishes its interim report
|
English | 7.0 KB | ||
| 2025-07-25 02:00 |
Earnings Release
EQS-News: BB Biotech Q2 2025: outperforms Nasdaq Biotech Index; strong USD retu…
|
English | 25.4 KB | ||
| 2025-07-25 02:00 |
Earnings Release
EQS-News: BB Biotech Q2 2025: Outperformance zum Nasdaq Biotech Index – Starke …
|
German | 29.1 KB | ||
| 2025-07-25 02:00 |
Report Publication Announcement
EQS-Adhoc: BB Biotech AG publishes its interim report
|
English | 5.3 KB | ||
| 2025-07-25 02:00 |
Report Publication Announcement
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
|
German | 5.6 KB |
Automate Your Workflow. Get a real-time feed of all BB Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BB Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BB Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-05 | N/A | Non-Executive member | Buy | None | 40,893.80 CHF |
| 2024-09-16 | N/A | Non-Executive member | Buy | None | 47,103.20 CHF |
| 2024-07-29 | N/A | Non-Executive member | Buy | None | 54,913.50 CHF |
| 2024-04-30 | N/A | Non-Executive member | Buy | None | 41,450.00 CHF |
| 2024-03-25 | N/A | Non-Executive member | Buy | None | 55,167.50 CHF |
| 2024-03-22 | N/A | Non-Executive member | Buy | None | 105,927.16 CHF |
Peer Companies
